Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The proteome of schizophrenia
Juliana Nascimento, Daniel Martins‐de‐Souza
Schizophrenia (2015) Vol. 1, Iss. 1
Open Access | Times Cited: 119

Showing 26-50 of 119 citing articles:

Development of the MAM model of schizophrenia in mice: Sex similarities and differences of hippocampal and prefrontal cortical function
Kleanthi Chalkiadaki, Aggeliki Velli, Evangelos Kyriazidis, et al.
Neuropharmacology (2018) Vol. 144, pp. 193-207
Open Access | Times Cited: 34
The Gut Microbiome in Psychosis From Mice to Men: A Systematic Review of Preclinical and Clinical Studies
Ann-Katrin Kraeuter, Riana Phillips, Zoltán Sarnyai
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 32
Plasma β-III tubulin, neurofilament light chain and glial fibrillary acidic protein are associated with neurodegeneration and progression in schizophrenia
Daniela Rodrígues-Amorím, Tania Rivera‐Baltanás, María del Carmen Vallejo-Curto, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 31
Mitochondrial, cell cycle control and neuritogenesis alterations in an iPSC-based neurodevelopmental model for schizophrenia
Giuliana S. Zuccoli, Juliana Nascimento, Pedro M. Moraes‐Vieira, et al.
European Archives of Psychiatry and Clinical Neuroscience (2023) Vol. 273, Iss. 8, pp. 1649-1664
Open Access | Times Cited: 10
Recent Advances in Schizophrenia Genomics and Emerging Clinical Implications
Tim B. Bigdeli, Philip D. Harvey
Psychiatric Clinics of North America (2025)
Closed Access
Directing neuronal cell fate in vitro: Achievements and challenges
Renzo J. M. Riemens, Daniël van den Hove, Manel Esteller, et al.
Progress in Neurobiology (2018) Vol. 168, pp. 42-68
Open Access | Times Cited: 31
The Nuclear Proteome of White and Gray Matter from Schizophrenia Postmortem Brains
Verônica M. Saia‐Cereda, Aline G. Santana, Andrea Schmitt, et al.
Complex Psychiatry (2017) Vol. 3, Iss. 1, pp. 37-52
Open Access | Times Cited: 29
Mitochondrial Dysfunction and Changes in High-Energy Compounds in Different Cellular Models Associated to Hypoxia: Implication to Schizophrenia
Luiz Silva, Mariana Dutra Brito, Jéssica Mayumi Camargo Yuzawa, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 27
Proteomics in Schizophrenia: A Gateway to Discover Potential Biomarkers of Psychoneuroimmune Pathways
Daniela Rodrígues-Amorím, Tania Rivera‐Baltanás, María del Carmen Vallejo-Curto, et al.
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 27
Computational chemoproteomics to understand the role of selected psychoactives in treating mental health indications
Jonathan Fine, Rachel M. Lackner, Ram Samudrala, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 26
Quantitative Subcellular Proteomics of the Orbitofrontal Cortex of Schizophrenia Patients
Erika Velásquez, Daniel Martins‐de‐Souza, Ingrid Velásquez, et al.
Journal of Proteome Research (2019) Vol. 18, Iss. 12, pp. 4240-4253
Closed Access | Times Cited: 26
Molecular linkage between post-traumatic stress disorder and cognitive impairment: a targeted proteomics study of World Trade Center responders
Pei Fen Kuan, Sean Clouston, Xiaohua Yang, et al.
Translational Psychiatry (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 24
Schizophrenia, a disease of impaired dynamic metabolic flexibility: A new mechanistic framework
Zoltán Sarnyai, Dorit Ben‐Shachar
Psychiatry Research (2024) Vol. 342, pp. 116220-116220
Open Access | Times Cited: 3
Peptidomic analysis of the anterior temporal lobe and corpus callosum from schizophrenia patients
Cecília C. Café-Mendes, Emer S. Ferro, Andréa da Silva Torrão, et al.
Journal of Proteomics (2016) Vol. 151, pp. 97-105
Closed Access | Times Cited: 25
Mechanisms of disordered neurodegenerative function: concepts and facts about the different roles of the protein kinase RNA-like endoplasmic reticulum kinase (PERK)
Yasmeen M. Taalab, Nour Ibrahim, Ahmed Maher, et al.
Reviews in the Neurosciences (2018) Vol. 29, Iss. 4, pp. 387-415
Closed Access | Times Cited: 24
Digging deeper in the proteome of different regions from schizophrenia brains
Guilherme Reis‐de‐Oliveira, Giuliana S. Zuccoli, Mariana Fioramonte, et al.
Journal of Proteomics (2020) Vol. 223, pp. 103814-103814
Closed Access | Times Cited: 22
Peripheral Blood-Based Gene Expression Studies in Schizophrenia: A Systematic Review
Vipul V. Wagh, Parin Vyas, Suchita Agrawal, et al.
Frontiers in Genetics (2021) Vol. 12
Open Access | Times Cited: 19
Epigenetic Treatment of Persistent Viral Infections
Walter H. Moos, Carl A. Pinkert, Michael H. Irwin, et al.
Drug Development Research (2016) Vol. 78, Iss. 1, pp. 24-36
Closed Access | Times Cited: 23
Altered apolipoprotein C expression in association with cognition impairments and hippocampus volume in schizophrenia and bipolar disorder
Christian Knöchel, Jonathan Kniep, Jason D. Cooper, et al.
European Archives of Psychiatry and Clinical Neuroscience (2016) Vol. 267, Iss. 3, pp. 199-212
Open Access | Times Cited: 21
Convolutional neural network in proteomics and metabolomics for determination of comorbidity between cancer and schizophrenia
Arthur T. Kopylov, Denis V. Petrovsky, Alexander A. Stepanov, et al.
Journal of Biomedical Informatics (2021) Vol. 122, pp. 103890-103890
Open Access | Times Cited: 17
Induced pluripotent stem cell-derived astrocytes from patients with schizophrenia exhibit an inflammatory phenotype that affects vascularization
Pablo Trindade, Juliana Nascimento, Bárbara S. Casas, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 2, pp. 871-882
Open Access | Times Cited: 12
Proteome-wide Mendelian randomization reveals the causal effects of immune-related plasma proteins on psychiatric disorders
Xinglun Dang, Meng Song, Luxian Lv, et al.
Human Genetics (2023) Vol. 142, Iss. 6, pp. 809-818
Closed Access | Times Cited: 7
NRN1 epistasis with BDNF and CACNA1C: mediation effects on symptom severity through neuroanatomical changes in schizophrenia
Carmen Almodóvar-Payá, Maria Guardiola-Ripoll, Maria Giralt‐López, et al.
Brain Structure and Function (2024) Vol. 229, Iss. 5, pp. 1299-1315
Open Access | Times Cited: 2
A reference library of peripheral blood mononuclear cells for SWATH‐MS analysis
Carolina S. Silva, Cátia Santa, Sandra I. Anjo, et al.
PROTEOMICS - CLINICAL APPLICATIONS (2016) Vol. 10, Iss. 7, pp. 760-764
Closed Access | Times Cited: 17
The state of the art of nanopsychiatry for schizophrenia diagnostics and treatment
Allan Radaic, Daniel Martins‐de‐Souza
Nanomedicine Nanotechnology Biology and Medicine (2020) Vol. 28, pp. 102222-102222
Closed Access | Times Cited: 16

Scroll to top